Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial

Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the site revision to v3.5.0, replacing the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T19:40:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.4.3; the previous v3.4.2 label was removed.
    Difference
    0.0%
    Check dated 2026-03-11T17:23:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Oropharynx cancer as a topic and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-02-25T11:15:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the page. Earlier entries, including a government funding notice and Revision: v3.4.1, appear to have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T10:20:30.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:43:17.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Additions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are UI and metadata updates rather than changes to core study content.
    Difference
    0.2%
    Check dated 2026-01-28T04:50:38.000Z thumbnail image

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.